Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Becker’s asked four health system strategic leaders to pick one operational process systems must rethink in 2026. If you are a COO or strategic leader in healthcare and are interested in joining ...

The Pathway Fellowship at Mayo Clinic in Florida is geared toward senior-level U.S. medical students who are focused on ...

The Company expects to provide a regulatory update after the receipt of official meeting minutes.

Radiopharmaceutical development and clinical translation face numerous scientific, ethical, and regulatory challenges, particularly within the pediatric population. Although molecular imaging holds ...

Dordaviprone is now a category 2A treatment for H3 K27M-mutant diffuse glioma in NCCN Guidelines, addressing an urgent unmet need. FDA accelerated approval was based on five nonrandomized trials, ...

We stand at an extraordinary crossroads in medicine. This year, a young patient at Children's Hospital of Philadelphia received a treatment that would have been pure science fiction just decades ago — ...

The term ‘mainstreaming’ was first used in 2003 by the Secretary of State for Health in the context of the genetics white paper Our Inheritance, Our Future when he argued that genomics must move from ...

In a typical undergraduate biochemistry course, two main educational objectives include (1) understanding and applying how genetic mutations can influence protein structure and function, and (2) ...

Evolent (NYSE: EVH) is a company built to help payers manage high-cost specialty care, focusing on areas such as oncology, cardiology, and musculoskeletal medicine. In the Journal of Clinical Pathways ...